Arthrex is a global medical device company and leader in new product development and medical education in orthopedics. The company competes against key players such as Zimmer Biomet, Smith + Nephew, and Johnson & Johnson Services Inc. in a $3.2 billion revenue business with significant global reach.
Cyborg Score Rationale
Arthrex generated annual revenue of $3.2 billion in 2026, reflecting strong market position and scale in the orthopedic surgical devices sector. The company's focus on minimally invasive technology, comprehensive product portfolio, and global operational footprint demonstrate competitive resilience and growth momentum.
Top Insights
Annual revenue reached $3.2 billion in 2026, reflecting robust demand across orthopedic markets
Global headquarters in Naples, FL with regional offices in Munich, Mexico City, and Singapore supporting worldwide market penetration
Released the TightRope® SB implant in February 2026, the first device on the market for anterior cruciate ligament reconstruction without metal components
Employee count reached 9,034 as of April 2026, demonstrating organizational scaling
Named Competitors
Zimmer Biomet — Global leader in musculoskeletal healthcare and orthopedic devices
Smith + Nephew — Leading specialty surgical device manufacturer for orthopedics and trauma
Johnson & Johnson — Diversified healthcare conglomerate with orthopedic device portfolio
NuVasive — Surgical solutions for spine and orthopedic procedures